Haleos Labs Ltd.

•

haleoslabs.comBSE: 540679NSE: HALEOSLABS

Market Cap₹ 444 Cr.

Current Price

High / Low₹ 1,774 / 1,091

Stock P/E28.0

Book Value₹ 720

Price to Book1.66

Dividend Yield0.10 %

ROCE14.0 %

ROE11.4 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Operating margins have improved to 12.0% from 8.7%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.99x)
Company generates healthy free cash flow
Company has a consistent dividend-paying track record
Company maintains a comfortable, low leverage position

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 9.2% over last 3 years
Company has a low return on capital employed of 11.7%
Company has delivered a poor sales growth of 5.3% over past five years
Growth is decelerating - 3Y profit CAGR (-5.6%) trails the 5Y trend (18.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	HALEOSLABS	1467.80	28.08	443.76	0.10	18.40	319.90	729.42	784.09	12.60	12.50

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	75	68	71	86	87	78	83	85	79	78	81	63	68
	69	58	62	76	73	67	70	80	68	67	69	57	63
Operating Profit	5	9	9	11	14	12	13	6	11	11	12	6	5
OPM %	6.87%	13.96%	12.66%	12.52%	15.91%	15.03%	15.77%	6.56%	13.70%	13.87%	14.32%	9.78%	7.11%
	1	0	1	2	0	1	0	2	1	0	0	1	0
Interest	2	2	2	3	2	2	2	2	2	2	1	1	2
Depreciation	3	3	3	3	2	3	3	3	3	3	3	3	3
Profit before Tax	1	5	5	8	10	9	9	3	7	7	7	3	5
Tax %	48.53%	34.80%	34.71%	25.03%	32.29%	29.79%	27.64%	19.82%	31.02%	29.36%	27.77%	29.56%	38.63%
Net Profit	1	3	3	6	6	6	6	3	5	5	5	2	3
	2.32	10.31	10.96	19.63	21.37	19.87	20.60	8.85	17.06	16.46	17.88	7.39	10.71

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	0	216	213	344	257	260	346	315	300	333	290
	0	187	200	312	233	230	314	289	265	289	256
Operating Profit	-0	28	13	32	24	30	31	26	35	44	33
OPM %	—	13.20%	6.21%	9.43%	9.26%	11.45%	9.09%	8.40%	11.51%	13.29%	11.52%
	0	2	3	3	2	1	14	5	4	4	2
Interest	0	6	4	5	5	5	5	5	9	8	6
Depreciation	0	6	6	6	7	7	8	8	10	10	11
Profit before Tax	-0	18	6	24	13	19	33	18	19	30	23
Tax %	-0.00%	29.89%	-1.64%	29.99%	31.42%	31.96%	23.03%	28.06%	31.64%	28.86%	31.00%
Net Profit	-0	13	7	17	9	13	25	13	13	21	16
EPS	0.00	42.81	21.50	55.02	30.26	43.56	83.95	43.72	43.22	70.69	—
Dividend Payout %	0.00%	0.00%	0.00%	2.73%	0.00%	3.44%	1.79%	3.43%	3.47%	2.12%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 5%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 18%
3 Years:: -6%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 12%
5 Years:: 11%
3 Years:: 9%
Last Year:: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0	0	3	3	3	3	3	3	3	3
	-0	82	85	102	110	123	148	161	173	194
	0	26	27	46	50	50	62	86	77	70
Trade Payables	0	55	44	84	45	62	71	55	50	46
	0	18	18	22	24	38	36	36	48	55
Total Liabilities	0	181	178	257	232	276	319	341	352	367
	0	73	68	87	94	101	99	140	138	150
Capital Work in Progress	0	0	7	1	2	3	21	1	6	0
	0	0	5	26	26	26	23	23	23	23
	0	44	49	74	61	59	81	80	75	61
	0	0	0	0	0	0	0	0	49	65
Cash & Bank	0	0	1	2	2	9	2	1	1	1
	0	64	47	66	46	79	93	96	59	67
Total Assets	0	181	178	257	232	276	319	341	352	367

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	25	9	34	17	26	-7	8	15	28
Cash from Investing	-8	-7	-43	-13	-6	-7	-28	-14	-14
Cash from Financing	-12	-1	18	-2	-8	15	23	-1	-14
	-0	0	2	-1	8	-8	-1	0	0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-1.85	12943.20	21.50	55.02	30.26	43.56	83.95	43.72	43.22	70.69
Book Value (₹)	-8.21	81838.70	292.42	347.23	374.61	417.88	500.16	542.55	582.90	652.19
Dividend per Share (₹)	0.00	0.00	0.00	1.50	0.00	1.50	1.50	1.50	1.50	1.50
Cash EPS (₹)	-1.85	0.00	40.37	74.10	54.22	67.42	110.38	70.75	77.13	104.61
PROFITABILITY
Operating Margin %	0.00%	13.16%	6.93%	9.31%	9.09%	10.85%	8.69%	8.34%	10.51%	12.02%
Net Margin %	0.00%	5.64%	2.76%	4.43%	3.24%	4.59%	6.69%	3.76%	3.97%	5.80%
ROE %	0.00%	31.63%	7.64%	17.20%	8.38%	10.99%	18.29%	8.39%	7.68%	11.45%
ROCE %	0.00%	45.72%	9.48%	21.82%	11.73%	14.36%	19.73%	10.23%	10.94%	14.03%
	-14.76%	14.28%	3.62%	7.65%	3.74%	5.19%	8.53%	4.00%	3.77%	5.95%
EFFICIENCY
Debtor Days	0	62	51	31	38	33	31	41	53	56
Inventory Days	0	70	72	60	87	76	67	84	86	67
Payable Days	0	84	137	102	145	140	116	120	117	103
	0	47	-14	-11	-20	-30	-18	5	22	20
FINANCIAL HEALTH
Debt to Equity (x)	-0.37x	0.32x	0.31x	0.45x	0.43x	0.35x	0.40x	0.52x	0.50x	0.40x
Interest Coverage (x)	0.00x	3.98x	2.52x	5.35x	3.61x	5.24x	8.05x	4.56x	3.12x	4.78x
	0.16x	1.35x	1.38x	1.19x	1.26x	1.28x	1.34x	1.50x	1.41x	1.40x
GROWTH
Revenue Growth %	0.00%	0.00%	-1.35%	61.58%	-25.35%	1.30%	32.80%	-8.79%	-4.83%	11.12%
Operating Profit Growth %	0.00%	0.00%	-46.04%	114.58%	-26.60%	21.24%	5.83%	-10.91%	30.71%	25.70%
Net Profit Growth %	0.00%	0.00%	-49.77%	155.84%	-45.01%	43.96%	92.75%	-47.92%	-1.15%	63.57%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.15%	63.57%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	15.71x	15.28x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	1.16x	1.66x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.22%	0.14%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	7.63x	8.38x

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.41	71.41	71.41	71.41	71.41	71.80	72.11	72.11
	0.02	0.00	0.00	0.03	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.03	0.29	0.30	0.31
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	28.57	28.59	28.59	28.56	28.57	27.91	27.60	27.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-05

General Updates

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange about Events Calendar (AGM)

2026-09-05

Record Date

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.

2026-09-01

Shareholders meeting

2026-09-01 - HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

2026-08-24

Updates

2026-08-24 - HALEOS LABS LIMITED has informed the Exchange regarding 'Communication To Shareholders (TDS Related)'.

2026-08-07

Copy of Newspaper Publication

2026-08-07 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

2026-08-05

Updates

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.

2026-08-05

Change in Director(s)

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding Change in Director(s) of the company.

2026-08-05

Outcome of Board Meeting

2026-08-05 - HALEOS LABS LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-30

Copy of Newspaper Publication

2026-07-30 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication (Postal Ballot)

News

Recent coverage and analyst commentary for HALEOSLABS

Loading news…

🤖

AI Stock Analyst

Haleos Labs Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account